Good Health Can’t Wait.

More documents

Recommendations

Info

Good Health Can’t Wait. Dr. Reddy’s Laboratories Limited CHART 1: MOVEMENT OF THE COMPANY’S SHARE PRICE ON NSE AND CNX NIFTY INDEX 150 140 130 120 110 100 90 80 APR 14 MAY 14 JUN 14 JUL 14 AUG 14 SEP 14 OCT 14 NOV 14 DR. REDDY’S SHARE PRICE S&P CNX NIFTY Notes: 1. All values are indexed to 100 as on 1 April 2014. 2. S&P CNX Nifty is a well diversified 50 stock index accounting for 23 sectors of the Indian economy. It is owned and managed by India Index Services and Products Ltd. (IISL), India’s first specialized company focused upon the index as a core product. CHART 2: MOVEMENT OF ADR PRICES AND S&P ADR INDEX 140 130 120 110 DEC 14 JAN 15 FEB 15 MAR 15 STOCK DATA Table 3 gives the monthly high/low and the total number of shares/ADRs traded per month on the BSE, NSE and the NYSE during FY2015. Chart 1 gives the movement of the Company’s share price on NSE vis-à-vis CNX Nifty during FY2015. Chart 2 gives the movement of Dr. Reddy’s ADR prices on NYSE vis-à-vis S&P ADR Index during FY2015. Chart 3 gives premium in percent on ADR traded on NYSE compared to price quoted at NSE during FY2015. SHAREHOLDING PATTERN AS ON 31 MARCH 2015 Tables 4 and 5 gives the data on shareholding classified on the basis of ownership and shareholders’ class, respectively. DIVIDEND HISTORY Chart 4 on page 76 shows the dividend history of the Company from the FY2005 to FY2015. 100 90 80 70 6 4 2 0 -2 -4 -6 APR 14 DR. REDDY’S ADR PRICE S&P ADR INDEX Notes: 1. All values are indexed to 100 as on 1 April 2014. 2. The S&P ADR Index is based on the non-US stocks comprising the S&P Global 1200 traded in the US exchanges. For details of the methodology used to compute this index please visit www.adr.com. CHART 3: PREMIUM ON ADR TRADED ON NYSE VERSUS PRICE QUOTED AT NSE APR 14 MAY 14 MAY 14 JUN 14 JUN 14 JUL 14 JUL 14 AUG 14 AUG 14 SEP 14 SEP 14 OCT 14 OCT 14 NOV 14 NOV 14 DEC 14 DEC 14 JAN 15 JAN 15 FEB 15 FEB 15 MAR 15 MAR 15 NOMINATION FACILITY Shareholders holding physical shares may, if they so desire, send their nominations in Form SH-13 or cancel/vary the nomination already made, in Form SH- 14 of the Companies (Share Capital and Debentures) Rules, 2015, as amended, to the Registrar and Transfer Agent of the Company. Those holding shares in dematerialised form may contact their respective Depository Participant (DP) to avail the nomination facility. EXCHANGE OF SHARE CERTIFICATES Standard Equity Fund Ltd. (SEFL), Cheminor Drugs Ltd. (CDL), American Remedies Ltd. (ARL) merged with Dr. Reddy’s Laboratories Ltd. in the years 1995, 2000 and 2001 respectively. Also, during the year 2001, the Company sub-divided the face value of its equity shares from ` 10/- to ` 5/-. Hence, the share certificates of the above three companies and old share certificates of ` 10/- face value are no longer valid. Notes: Premium has been calculated on a daily basis using RBI reference exchange rate. 74
Statutory Reports • Additional Shareholders’ Information Annual Report 2014 - 15 TABLE 3 HIGH, LOW AND NUMBER OF SHARES TRADED PER MONTH ON BSE, NSE AND NYSE DURING FY2015 BSE NSE NYSE MONTH NO. OF NO. OF NO. OF HIGH (`) LOW (`) HIGH (`) LOW (`) HIGH (US$) LOW (US$) SHARES SHARES ADRs (1) April 2014 2,783.00 2,522.00 515,892 2,781.75 2,520.05 7,367,523 45.32 41.95 6,582,183 May 2014 2,753.00 2,250.00 1,117,007 2,755.00 2,246.50 15,198,317 46.24 38.23 9,833,008 June 2014 2,623.00 2,293.00 642,837 2,630.20 2,291.15 9,302,102 43.34 39.01 7,148,539 July 2014 2,852.00 2,598.10 578,826 2,849.95 2,599.65 7,465,526 47.01 43.03 6,013,330 August 2014 2,969.00 2,711.90 330,630 2,975.00 2,711.10 6,288,749 49.22 44.04 4,608,411 September 2014 3,353.85 2,942.20 396,840 3,356.50 2,941.20 6,938,968 53.67 48.48 5,258,383 October 2014 3,280.00 2,883.40 427,651 3,277.00 2,867.00 5,939,013 52.79 45.67 5,621,862 November 2014 3,635.00 3,172.75 324,766 3,639.00 3,168.70 5,346,124 58.85 51.92 3,678,414 December 2014 3,662.00 3,060.00 496,000 3,666.25 3,057.00 13,033,959 59.02 48.34 6,879,673 January 2015 3,400.00 3,013.55 753,968 3,389.75 3,010.00 8,421,771 54.65 47.52 6,576,376 February 2015 3,431.00 3,010.00 432,889 3,424.95 3,007.00 6,140,459 54.60 49.01 6,530,176 March 2015 3,570.00 3,308.00 335,451 3,575.00 3,300.15 6,349,966 58.25 53.14 7,073,687 (1) One ADR is equal to one equity share. TABLE 4 DISTRIBUTION OF SHAREHOLDINGS ON THE BASIS OF OWNERSHIP AS ON 31 MARCH 2015 AS ON 31 MARCH 2014 NO. OF SHARES % OF TOTAL NO. OF SHARES % OF TOTAL % CHANGE Promoters’ Holding – Individuals 3,688,528 2.16 3,688,528 2.17 (0.01) – Companies 39,729,284 23.32 39,729,284 23.35 (0.03) Sub-Total 43,417,812 25.48 43,417,812 25.52 (0.04) (1) Indian Financial Institutions 3,093,029 1.82 2,278,743 1.34 0.48 Banks 163,268 0.10 102,681 0.06 0.04 Mutual Funds/UTI 6,010,819 3.52 8,320,359 4.89 (1.37) Foreign holdings – Foreign Institutional Investors 66,211,413 38.86 58,353,621 34.30 4.56 – Non Resident Indians 2,160,946 1.27 2,276,099 1.34 (0.07) – ADRs/Foreign Nationals 28,779,741 16.89 30,648,384 18.02 (1.13) Sub total 106,419,216 62.46 101,979,887 59.95 2.51 Indian Public and Corporates 20,544,146 12.06 24,711,169 14.53 (2.47) Total 170,381,174 100.00 170,108,868 100.00 0.00 (1) Change in percentage due to further ESOP allotment. TABLE 5 DISTRIBUTION OF SHAREHOLDING ACCORDING TO SHAREHOLDERS’ CLASS AS ON 31 MARCH 2015 SHARES HELD NO. OF SHAREHOLDERS % OF SHAREHOLDERS NO. OF SHARES HELD % OF SHAREHOLDING 1 – 5,000 73,520 98.49 10,656,056 6.25 5,001 – 10,000 470 0.63 3,264,902 1.92 10,001 – 20,000 254 0.34 3,592,728 2.11 20,001 – 30,000 85 0.11 2,080,645 1.22 30,001 – 40,000 49 0.06 1,730,945 1.01 40,001 – 50,000 21 0.03 948,272 0.56 50,001 – 100,000 86 0.12 5,879,449 3.45 100,001 and above 162 0.22 113,454,320 66.59 Total (Excluding ADRs) 74,647 100.00 141,607,317 83.11 Equity shares underlying ADRs (1) 1 0.00 28,773,857 16.89 Total 74,648 100.00 170,381,174 100.00 (1) Held by beneficial owners outside India. 75
Page 1 and 2:
ANNUAL REPORT 2014-15 Good Health C
Page 3 and 4:
Our Brand We are in the business of
Page 5 and 6:
Corporate Overview Annual Report 20
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26: Corporate Overview Annual Report 20
Page 27 and 28: Corporate Overview Annual Report 20
Page 29 and 30: Statutory Reports • Business Resp
Page 43 and 44: Statutory Reports • Management Di
Page 57 and 58: Statutory Reports • Corporate Gov
Page 73 and 74: Statutory Reports • Additional Sh
Page 75: Statutory Reports • Additional Sh
Page 87 and 88: Statutory Reports • Board’s Rep
Page 111 and 112: Standalone Financial Statements Ann
Page 127 and 128:
Standalone Financial Statements Ann
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Consolidated Financial Statements A
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Notice Annual Report 2014 - 15 NOTI
Page 229 and 230:
E-Voting Annual Report 2014 - 15 IN
Page 231:
Dr. Reddy’s Laboratories Limited
Page 235 and 236:
The future belongs, not to those wh
show all

Good Health Can’t Wait.

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?